tradmap

ASPN Financials Aspen Aerogels Inc

14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 22.0% per year over the past 5 years.
  • Operating margin has contracted, at -139.5% in the latest year.

Financial health

  • The company holds more cash ($157M) than total debt ($65M).
  • Total debt has grown faster than revenue (77.6% vs 22.0% per year).
  • The company is unprofitable; at its current free-cash-flow burn it has roughly 34.3 years of cash runway.
Revenue & net income
-$390M $32M $453M $0 2012 2014 2016 2018 2020 2022 2024
RevenueNet income
Margins (gross / operating / net)
-144% -52% 40% 0% 2012 2014 2016 2018 2020 2022 2024
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-165% -44% 77% 0% 2012 2014 2016 2018 2020 2022 2024
ROEROA
Free cash flow (CFO − capex)
-$272M -$136M $0 2012 2014 2016 2018 2020 2022 2024
Free cash flow
Cash vs total debt
$0 $141M $281M 2012 2014 2016 2018 2020 2022 2024
CashTotal debt
Cash flow: operating / investing / financing
-$178M $150M $478M $0 2012 2014 2016 2018 2020 2022 2024
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $271M -$390M 17.0% -139.5% -165.4% -95.8% -$5M $65M $157M
2024 $453M $13M 40.4% 12.0% 2.2% 1.5% -$41M $115M $221M
2023 $239M -$46M 23.8% -20.6% -9.4% -6.5% -$218M $140M
2022 $180M -$83M 2.8% -43.9% -18.5% -12.9% -$272M $281M
2021 $122M -$37M 8.2% -33.4% -28.9% -20.3% -$32M $77M
2020 $100M -$22M 14.6% -21.5% -32.1% -22.4% -$13M $4M $16M
2019 $139M -$15M 18.9% -10.2% -24.7% -14.1% -$3M $4M
2018 $104M -$34M 12.1% -32.5% -49.0% -34.8% -$12M $3M
2017 $112M -$19M 16.7% -17.1% -19.1% -15.6% -$11M $11M
2016 $118M -$12M 19.8% -9.5% -10.4% -8.9% -$14M $18M
2015 -$6M -5.2% -4.6% $33M
2014 -$66M -53.6% -45.7% $50M
2013 -$48M 76.8% -52.8% $2M
2012 -$56M 46.5% $1M

Valuation over time

How the market has priced ASPN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 36.7 73.5 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 5.2 10.4 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is ASPN growing its revenue and profit?

Over the past 5 years, Aspen Aerogels Inc's revenue has grown 22.0% per year. These are computed facts, not advice.

How much debt does ASPN have?

As of FY2025, Aspen Aerogels Inc reported $65M of total debt against $157M of cash.

What is ASPN's profit margin?

In FY2025, gross margin was 17.0%, operating margin -139.5%, and net margin -143.7%.

What is ASPN's P/E ratio?

As of Sep '26, Aspen Aerogels Inc traded at a price-to-earnings ratio of about 20.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.